Evidence of artemisinin-resistant malaria in we... [N Engl J Med. 2008] - PubMed

loading

Artemisinin resistance in Plasmodium falciparum malaria. [N Engl J Med. 2009]
Artemisinin resistance in Plasmodium falciparum malaria.
Taylor SM, Juliano JJ, Meshnick SR. N Engl J Med. 2009 Oct 29; 361(18):1807; author reply 1808.
The last man standing is the most resistant: eliminating artemisinin-resistant malaria in Cambodia. [Malar J. 2009]
The last man standing is the most resistant: eliminating artemisinin-resistant malaria in Cambodia.
Maude RJ, Pontavornpinyo W, Saralamba S, Aguas R, Yeung S, Dondorp AM, Day NP, White NJ, White LJ. Malar J. 2009 Feb 20; 8:31. Epub 2009 Feb 20.
Review Emerging drug--resistance and guidelines for treatment of malaria. [J Coll Physicians Surg Pak. 2004]
Review Emerging drug--resistance and guidelines for treatment of malaria.
Khan MA, Smego RA Jr, Razi ST, Beg MA. J Coll Physicians Surg Pak. 2004 May; 14(5):319-24.
Artemisinin resistance in Plasmodium falciparum malaria. [N Engl J Med. 2009]
Artemisinin resistance in Plasmodium falciparum malaria.
Htut ZW. N Engl J Med. 2009 Oct 29; 361(18):1807-8; author reply 1808.
Review Artemisinin resistance: current status and scenarios for containment. [Nat Rev Microbiol. 2010]
Review Artemisinin resistance: current status and scenarios for containment.
Dondorp AM, Yeung S, White L, Nguon C, Day NP, Socheat D, von Seidlein L. Nat Rev Microbiol. 2010 Apr; 8(4):272-80. Epub 2010 Mar 8.

The Role of Pfmdr1 and Pfcrt in Changing Chloroquine, Amodiaquine, Mefloquine and Lumefantrine Susceptibility in Western-Kenya P. falciparum Samples during 2008-2011. [PLoS One. 2013]
The Role of Pfmdr1 and Pfcrt in Changing Chloroquine, Amodiaquine, Mefloquine and Lumefantrine Susceptibility in Western-Kenya P. falciparum Samples during 2008-2011.
Eyase FL, Akala HM, Ingasia L, Cheruiyot A, Omondi A, Okudo C, Juma D, Yeda R, Andagalu B, Wanja E, et al. PLoS One. 2013; 8(5):e64299. Epub 2013 May 13.
Made in Europe: will artemisinin resistance emerge in French Guiana? [Malar J. 2013]
Made in Europe: will artemisinin resistance emerge in French Guiana?
Nacher M, Guérin PJ, Demar-Pierre M, Djossou F, Nosten F, Carme B. Malar J. 2013 May 4; 12:152. Epub 2013 May 4.
Impact of methylene blue and atorvastatin combination therapy on the apparition of cerebral malaria in a murine model. [Malar J. 2013]
Impact of methylene blue and atorvastatin combination therapy on the apparition of cerebral malaria in a murine model.
Dormoi J, Briolant S, Desgrouas C, Pradines B. Malar J. 2013 Apr 15; 12(1):127. Epub 2013 Apr 15.

Related Citations
Calculated set of PubMed citations closely related to the selected article(s) retrieved using a word weight algorithm. Related articles are displayed in ranked order from most to least relevant, with the “linked from” citation displayed first.
Compound (MeSH Keyword)
PubChem chemical compound records that are classified under the same Medical Subject Headings (MeSH) controlled vocabulary as the current articles.
Substance (MeSH Keyword)
PubChem chemical substance (submitted) records that are classified under the same Medical Subject Headings (MeSH) controlled vocabulary as the current articles.
Cited in PMC
Full-text articles in the PubMed Central Database that cite the current articles.

Evidence of artemisinin-resistant malaria in western Cambodia.
Evidence of artemisinin-resistant malaria in western Cambodia.
N Engl J Med. 2008 Dec 11 ;359(24):2619-20. doi: 10.1056/NEJMc0805011. Epub 2008 Dec 8 .

PubMed

Your browsing activity is empty.

Activity recording is turned off.

PubMed